Literature DB >> 2856896

Drug management of pain in cancer patients.

C B Tuttle.   

Abstract

Chronic severe cancer pain is often not well controlled because both patient and physician have a poor understanding of the nature of the pain and of the actions of various potent analgesics. Physicians often fail to tailor analgesic dosages to the needs of the individual and unnecessarily limit the dosage because they have an ill founded fear that the patient will become addicted. The basis of rational management of cancer pain with drugs is an appropriate analgesic given regularly in doses adequate to suppress pain continuously. This review compares the potent analgesics and identifies and discusses those that have a role in treating chronic cancer pain. It emphasizes the value of morphine sulfate and gives information on starting and individualizing dosages and managing side effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2856896      PMCID: PMC1346740     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  93 in total

1.  Fundamental considerations of chronic pain therapy.

Authors:  J J Bonica
Journal:  Postgrad Med       Date:  1973-05       Impact factor: 3.840

2.  The treatment of chronic pain with psychotropic drugs.

Authors:  H Merskey; R A Hester
Journal:  Postgrad Med J       Date:  1972-10       Impact factor: 2.401

3.  A comparative evaluation of marketed analgesic drugs.

Authors:  C G Moertel; D L Ahmann; W F Taylor; N Schwartau
Journal:  N Engl J Med       Date:  1972-04-13       Impact factor: 91.245

4.  Cutaneous complications of pentazocine injections.

Authors:  D L Parks; H O Perry; S A Muller
Journal:  Arch Dermatol       Date:  1971-09

5.  Cutaneous complications of parenterally administered pentazocine.

Authors:  J B Winfield; K Greer
Journal:  JAMA       Date:  1973-10-08       Impact factor: 56.272

6.  Hospitalized pentazocine abusers.

Authors:  D W Swanson; R L Weddige; R M Morse
Journal:  Mayo Clin Proc       Date:  1973-02       Impact factor: 7.616

7.  Undertreatment of medical inpatients with narcotic analgesics.

Authors:  R M Marks; E J Sachar
Journal:  Ann Intern Med       Date:  1973-02       Impact factor: 25.391

8.  The hallucinatory effect of pentazocine (Talwin).

Authors:  N DeNosaquo
Journal:  JAMA       Date:  1969-10-20       Impact factor: 56.272

9.  Patterns of pentazocine abuse and addiction.

Authors:  J A Inciardi; C D Chambers
Journal:  N Y State J Med       Date:  1971-07-15

10.  The distress of dying.

Authors:  W Dewi Rees
Journal:  Br Med J       Date:  1972-07-08
View more
  5 in total

1.  A comparison of the hypoalgesic effect of paracetamol in slow-release and plain tablets on laser-induced pain.

Authors:  J C Nielsen; P Bjerring; L Arendt-Nielsen
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

2.  Continuous intravenous infusion of opioid analgesics for severe pain.

Authors:  E Latimer; F Burge
Journal:  Can Fam Physician       Date:  1989-09       Impact factor: 3.275

3.  Palliative Services in Long-Term Care: Meeting the special needs of veterans.

Authors:  V M Hayes; J Carling; L Campbell
Journal:  Can Fam Physician       Date:  1992-10       Impact factor: 3.275

4.  A practical approach to improving pain control in cancer patients.

Authors:  M L Brigden; J B Barnett
Journal:  West J Med       Date:  1987-05

5.  Control of severe pain with sustained-release morphine tablets v. oral morphine solution.

Authors:  W W Arkinstall; B R Goughnour; J A White; J H Stewart
Journal:  CMAJ       Date:  1989-03-15       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.